An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia

被引：5
|
作者：
Dursun, S [1 ]
机构：
[1] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2005年 / 19卷 / 05期
关键词：
D O I：
10.1177/0269881105057347
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [41] Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia
    Rubio, Jose M.
    Mychaskiw, Marko A.
    Lim, Sangtaeck
    Suett, Mark
    Wang, Yitong
    Tian, Marc
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (02)
  • [42] Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
    Christina Leotsakou
    Sofia Kessidou
    Aikaterini Kalogeropoulou
    Ioanna Fotara
    Perikles Robotis
    Christina Karkatzouli
    Demetrios Gousis
    Athanasios Demetriades
    Maria Giovanoglou
    Perikles Paterakis
    Annals of General Psychiatry, 7 (Suppl 1)
  • [43] COST-EFFECTIVENESS OF INJECTABLE ATYPICAL LONG-ACTING ANTIPSYCHOTICS FOR CHRONIC SCHIZOPHRENIA IN POLAND
    Hemels, M.
    Einarson, T. R.
    Zilbershtein, R.
    Schubert, A.
    Skrzekowska-Baran, I
    Van Impe, K.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
  • [44] Long-term impact of a long-acting atypical antipsychotic
    Berry, S
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 87 - 87
  • [45] Guidelines for the use of long-acting injectable atypical antipsychotics
    不详
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (01) : 120 - 131
  • [46] A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
    Nasrallah, Henry A.
    Gopal, Srihari
    Gassmann-Mayer, Cristiana
    Quiroz, Jorge A.
    Lim, Pilar
    Eerdekens, Marielle
    Yuen, Eric
    Hough, David
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (10) : 2072 - 2082
  • [47] Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
    Maini, Kunal
    Gould, Haley
    Hicks, Jessica
    Iqbal, Fatima
    Patterson, James, II
    Edinoff, Amber N.
    Cornett, Elyse M.
    Kaye, Adam M.
    Viswanath, Omar
    Urits, Ivan
    Kaye, Alan D.
    NEUROLOGY INTERNATIONAL, 2021, 13 (03) : 279 - 296
  • [48] A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
    Henry A Nasrallah
    Srihari Gopal
    Cristiana Gassmann-Mayer
    Jorge A Quiroz
    Pilar Lim
    Mariëlle Eerdekens
    Eric Yuen
    David Hough
    Neuropsychopharmacology, 2010, 35 : 2072 - 2082
  • [49] Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia
    Robinson, Delbert G.
    Suett, Mark
    Wilhelm, Amanda
    Chaijale, Nayla
    Franzenburg, Kelli R.
    Gandhi, Sanjay
    Cloud, Blaine
    Mychaskiw, Marko
    ADVANCES IN THERAPY, 2023, 40 (05) : 2249 - 2264
  • [50] Use of a long-acting atypical antipsychotic in bipolar patients
    Singh, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S236 - S236
12345